NEOGEN CORP is 1.2x more valuable than Intellia Therapeutics, Inc. by market capitalization ($2.00 B vs $1.70 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | NEOG | NTLA |
|---|---|---|
| Market cap | $2.00 B | $1.70 B |
| US-listed rank | #2099 | #2213 |
| Revenue (latest FY) | $894.66M | $67.67M |
| Net income (latest FY) | -$1.09B | -$412.69M |
| Net margin | -122.1% | -609.9% |
| SEC filings | 1,896 | 687 |
NEOGEN CORP is 1.2x more valuable than Intellia Therapeutics, Inc. by market capitalization ($2.00 B vs $1.70 B).
In their latest fiscal years, NEOGEN CORP reported $894.66M in revenue while Intellia Therapeutics, Inc. reported $67.67M.
Full pages: NEOGEN CORP and Intellia Therapeutics, Inc., or browse the full rankings.